BioSpace News Archive

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 22 new employees with a grant date of October 3, 2022, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

NLS Pharmaceutics Ltd. announces that on September 29, 2022, it received a determination letter of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the Staff’s determination that, unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”), the Company’s securities would be subject to delisting from The Nasdaq Capital Market

Bionix announced its attendance at the American Academy of Pediatrics (AAP) 2022 National Conference & Exhibition in Anaheim, CA , beginning October 7 through October 11, 2022.

Biofrontera Inc. today announced preliminary unaudited product revenues for the three and nine months ended September 30, 2022.

Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc.

MiNK Therapeutics , Inc. announced the company will host an in-person and virtual Research & Development Day on Thursday, November 10th, 2022 from 4:00-6:00 PM ET in Boston, MA, and via webcast.

MediXall Group Inc., an innovative healthcare solutions provider, announced that VetCV has selected MediXall’s wholly-owned subsidiary, Health Karma, Inc., to drive greater access to care for US Veterans.

GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armyworm.

Lytix Biopharma today announces that an abstract has been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022.

SYNAPS Dx announces support for the nations’ payers in their coverage and prescribing determinations for the AD drug, lecanemab when it is approved as expected by the FDA.